Design Therapeutics Inc. (DSGN)
DSGN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.78
-10.36% on the day
Market cap
$612.0M
Small cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$69.8M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | DSGN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001807120 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$69.8M |
| Operating income | -$79.5M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $16.9M |
| Total assets | $226.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-05-07 |
| Latest annual report | 10-K | 2026-03-09 |
| Latest quarterly / interim | 10-Q | 2026-08-03 |
| Latest current report | 8-K | 2026-08-03 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 264 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -17.5% |
| 1 month | -21.1% |
| 3 months | -23.6% |
| Year to date | +2.8% |
| 1 year | +48.5% |
| From 52-week high | -39.5% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals Inc. | $7.02 | -4.62% | $614.2M |
| ZVRA | Zevra Therapeutics Inc. | $10.39 | -8.22% | $617.0M |
| WVE | Wave Life Sciences Inc. | $3.14 | -4.27% | $618.7M |
| ABUS | Arbutus Biopharma Corporation | $4.11 | -0.96% | $630.0M |
| IRWD | Ironwood Pharmaceuticals Inc. | $3.59 | -4.52% | $593.2M |
| CLYM | Climb Bio Inc. | $10.31 | -4.80% | $592.2M |
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier